Isramco Negev 2 Limited Partnership
Isramco Negev 2 Limited Partnership Fundamental Analysis
Isramco Negev 2 Limited Partnership (ISRMF) shows moderate financial fundamentals with a PE ratio of 14.83, profit margin of 25.92%, and ROE of 18.58%. The company generates $0.4B in annual revenue with weak year-over-year growth of -16.21%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 36.2/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze ISRMF's fundamental strength across five key dimensions:
Efficiency Score
WeakISRMF struggles to generate sufficient returns from assets.
Valuation Score
ExcellentISRMF trades at attractive valuation levels.
Growth Score
WeakISRMF faces weak or negative growth trends.
Financial Health Score
ExcellentISRMF maintains a strong and stable balance sheet.
Profitability Score
ExcellentISRMF achieves industry-leading margins.
Key Financial Metrics
Is ISRMF Expensive or Cheap?
P/E Ratio
ISRMF trades at 14.83 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, ISRMF's PEG of -0.76 indicates potential undervaluation.
Price to Book
The market values Isramco Negev 2 Limited Partnership at 2.82 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 5.25 times EBITDA. This is generally considered low.
How Well Does ISRMF Make Money?
Net Profit Margin
For every $100 in sales, Isramco Negev 2 Limited Partnership keeps $25.92 as profit after all expenses.
Operating Margin
Core operations generate 40.98 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $18.58 in profit for every $100 of shareholder equity.
ROA
Isramco Negev 2 Limited Partnership generates $8.19 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Isramco Negev 2 Limited Partnership generates strong operating cash flow of $229.18M, reflecting robust business health.
Free Cash Flow
Isramco Negev 2 Limited Partnership generates strong free cash flow of $189.80M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $0.07 in free cash annually.
FCF Yield
ISRMF converts 11.03% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
14.83
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.76
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.82
vs 25 benchmark
P/S Ratio
Price to sales ratio
3.85
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.72
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.17
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.19
vs 25 benchmark
ROA
Return on assets percentage
0.08
vs 25 benchmark
ROCE
Return on capital employed
0.15
vs 25 benchmark
How ISRMF Stacks Against Its Sector Peers
| Metric | ISRMF Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 14.83 | 21.16 | Better (Cheaper) |
| ROE | 18.58% | 975.00% | Weak |
| Net Margin | 25.92% | -58736.00% (disorted) | Strong |
| Debt/Equity | 0.72 | -0.49 (disorted) | Distorted |
| Current Ratio | 1.17 | 5.15 | Neutral |
| ROA | 8.19% | -11053687.00% (disorted) | Weak |
ISRMF outperforms its industry in 2 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Isramco Negev 2 Limited Partnership's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
2.34%
Industry Style: Cyclical, Value, Commodity
GrowingEPS CAGR
-47.67%
Industry Style: Cyclical, Value, Commodity
DecliningFCF CAGR
-22.36%
Industry Style: Cyclical, Value, Commodity
Declining